ED
EMN icon

Exane Derivatives’s Eastman Chemical EMN Stock Holding History

Exane Derivatives’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-624
Closed -$69.9K – 844
2022
Q1 		$69.9K Buy
+624
New +$73.1K 0.02% 521
2021
Q2 		– Sell
-731
Closed -$87.8K – 1057
2021
Q1 		$80.5K Buy
731
+700
+2,258% +$76K 0.02% 452
2020
Q4 		$3.11K Sell
31
-8
-21% -$742 ﹤0.01% 590
2020
Q3 		$3.05K Sell
39
-28,700
-100% -$2.16M ﹤0.01% 539
2020
Q2 		$2M Buy
28,739
+28,734
+574,680% +$1.81M 0.53% 51
2020
Q1 		$233 Hold
5
– – ﹤0.01% 651
2019
Q4 		$381 Hold
5
– – ﹤0.01% 632
2019
Q3 		$369 Hold
5
– – ﹤0.01% 603
2019
Q2 		$389 Hold
5
– – ﹤0.01% 610
2019
Q1 		$379 Hold
5
– – ﹤0.01% 552
2018
Q4 		$365 Buy
+5
New +$399 ﹤0.01% 617
2018
Q3 		– Sell
-14
Closed -$1.42K – 706
2018
Q2 		$1.42K Sell
14
-22,328
-100% -$2.36M ﹤0.01% 509
2018
Q1 		$2.33M Buy
22,342
+22,336
+372,267% +$2.26M 0.47% 46
2017
Q4 		$557 Sell
6
-1
-14% -$91 ﹤0.01% 504
2017
Q3 		$633 Sell
7
-28,448
-100% -$2.42M ﹤0.01% 470
2017
Q2 		$2.39M Buy
28,455
+28,450
+569,000% +$2.29M 0.51% 43
2017
Q1 		$404 Hold
5
– – ﹤0.01% 435
2016
Q4 		$376 Hold
5
– – ﹤0.01% 493
2016
Q3 		$338 Hold
5
– – ﹤0.01% 501
2016
Q2 		$339 Hold
5
– – ﹤0.01% 440
2016
Q1 		$361 Sell
5
-77
-94% -$5.04K ﹤0.01% 490
2015
Q4 		$5.54K Sell
82
-256,723
-100% -$18M ﹤0.01% 359
2015
Q3 		$16.6M Buy
256,805
+256,723
+313,077% +$19M 2.1% 25
2015
Q2 		$6.71K Hold
82
– – ﹤0.01% 384
2015
Q1 		$5.68K Hold
82
– – ﹤0.01% 402
2014
Q4 		$6.22K Buy
+82
New +$6.48K ﹤0.01% 425

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Exane Derivatives's EMN Position: Q2 2022 in Review

Exane Derivatives sold out of Eastman Chemical (EMN) in Q2 2022, closing a stake of 624 shares — an estimated $69.9K sold.

Exane Derivatives first reported a position in EMN in Q4 2014 and held it in 26 quarters. The position peaked at $16.6M in Q3 2015. 688 funds tracked by Wall St. Rank hold EMN as of Q2 2022.

  • Exane Derivatives reported no remaining Eastman Chemical position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 624 Eastman Chemical shares in Q2 2022, an estimated $69.9K.
  • Exane Derivatives first reported a position in Eastman Chemical in Q4 2014 and held it in 26 quarters.
  • Exane Derivatives's Eastman Chemical position peaked at $16.6M in Q3 2015.
  • 688 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.